基于不同钙释放机理的花萼海绵诱癌素A与去乙酰毛花苷的正性肌力作用研究
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Comparative Studies of Calyculin A and Deslanoside on Rat Isolated Heart Inotropy and Their Underlying Mechanism
  • 作者:谢铭 ; 黄惠丽 ; 张文慧 ; 高丽 ; 陈龙
  • 英文作者:XIE Ming;HUANG Hui-li;ZHANG Wen-hui;GAO Li;CHEN Long;National Standard Laboratory of Pharmacology for Chinese Materia Medica,Nanjing University of Chinese Medicine;Institute of Chinese Medicine of Taizhou China Medical City;
  • 关键词:花萼海绵诱癌素 ; 去乙酰毛花苷 ; 离体心脏 ; 钙释放
  • 英文关键词:calyculin A;;deslanoside;;isolated heart;;Ca2+ transient
  • 中文刊名:NJZY
  • 英文刊名:Journal of Nanjing University of Traditional Chinese Medicine
  • 机构:南京中医药大学国家科技部规范化中药药理实验室;泰州中国医药城中医药研究院;
  • 出版日期:2018-11-08 22:15
  • 出版单位:南京中医药大学学报
  • 年:2018
  • 期:v.34
  • 基金:泰州中国医药城第四批“113人才计划”(2016024);; 江苏省自然科学基金(BK20151355)
  • 语种:中文;
  • 页:NJZY201806016
  • 页数:4
  • CN:06
  • ISSN:32-1247/R
  • 分类号:73-76
摘要
目的与洋地黄类正性肌力代表药去乙酰毛花苷比较,研究蛋白磷酸酶(PP)抑制剂花萼海绵诱癌素A(Calyculin A)对心脏收缩力作用特点,分析Calyculin A正性肌力作用的钙释放机理。探讨能否以PP为靶点,开发正性肌力药物治疗心力衰竭。方法分别用Calyculin A(1,4,10nmol/L)和去乙酰毛花苷(0.1,1,10μmol/L)对大鼠离体心脏灌流,分析大鼠心率(HR)、左心室舒张压(LVDP)和最大上升速率(+dp/dtmax)的变化。采用Calyculin A(100nmol/L)和去乙酰毛花苷(10μmol/L)对大鼠左心室心肌细胞进行灌流,测定钙释放幅值、舒张期胞浆钙浓度(Ibaseline)及胞浆钙浓度恢复到静息状态值50%水平的时间(CTD50);分析Calyculin A(100nmol/L)和去乙酰毛花苷(10μmol/L)对咖啡因(20mmol/L)诱导的大鼠心肌细胞钙释放的影响,分析肌浆网钙泵活性(SERCA2a)、钠-钙交换体(NCX)及肌膜钙泵(PMCA)综合活性的变化。结果 Calyculin A(1,4,10nmol/L)与去乙酰毛花苷(0.1,1,10μmol/L)均能显著增加离体大鼠LVDP和+dp/dtmax(P<0.05),且减慢HR(P<0.05),并呈现浓度依赖性。Calyculin A(100nmol/L)与去乙酰毛花苷(10μmol/L)均显著增加钙释放幅值(P<0.05);Calyculin A还能显著降低Ibaseline(P<0.05),显著缩短CTD50(P<0.05)。Calyculin A(100nmol/L)显著增加肌浆网SERCA2a的速率常数(P<0.05);去乙酰毛花苷(10μmol/L)增加(NCX+PMCA)的速率常数(P<0.05),导致肌浆网SERCA2a在胞浆回吸收中所发挥作用的百分比下降(P<0.05)。结论 Calyculin A与去乙酰毛花苷对大鼠离体心脏作用没有显著区别,但Calyculin A通过增强肌浆网SERCA2a的活性,增加钙释放幅值并降低Ibaseline实现其正性肌力作用。Calyculin A的作用靶点PP,可作为一个潜在靶点用于开发正性肌力药物。
        OBJECTIVE To investigate the inotropic effect and its underlying mechanism of calyculin A,aprotein phosphatase(PP)inhibitor,compared to deslanoside,a digitalis positive inotropic agent.To provide inputs whether PP can be served as a potential therapeutic target to develop pharmacological inotropic agents in treatment of heart failure.METHODS Ex vivo study was used to record the effects of calyculin A and deslanoside on rat isolated contractilities.They were perfused to follow in order:normal perfusion solution→calyculin A(1,4,10 nmol/L)or normal perfusion solution→deslanoside(0.1,1,10μmol/L).Ca~(2+) transients triggered by field stimulation and by caffeine(20 mmol/L)were measured to analyze the Ca~(2+) handling effects of calyculin A(100 nmol/L)and deslanoside(10μmol/L).RESULTS Both calyculin A(1,4,10 nmol/L)and deslanoside(0.1,1,10μmol/L)significantly increased the left ventricular developed pressure and the peak rate of rise of left pressure(P<0.05)and decreased the heart rate(P<0.05).Calyculin A(100 nmol/L)and deslanoside(10μmol/L)significantly increased the amplitude of Ca~(2+) transient and shortened the Ca~(2+) transient duration at 50% full recovery level(P<0.05);Calyculin A also lowered diastolic cytoplasm Ca~(2+) concentration(P<0.05).Calyculin A(100 nmol/L)significantly increased the SERCA2 aactivity and combinational activities of Na+-Ca~(2+) exchanger(NCX)and plasma membrane Ca~(2+) -ATPase(PMCA)(P<0.05);Deslanoside(10μmol/L)only increased combinational activities of NCX and PMCA(P<0.05),resulting in lowering percentage of contribution of SERCA2 ain Ca~(2+) reuptake phase of Ca~(2+) transient(P<0.05).CONCLUSIONCalyculin A increases the amplitude of Ca~(2+) transient by enhancing activity of SERCA2 aand combinational activities of NCX and PMCA,resulting in the positive inotropy and favorable relaxation.PP can be a potential therapeutic target to develop pharmacological inotropic agents in treatment of heart failure.
引文
[1]DIGITALIS INVESTIGATION GROUP.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336(8):525-533.
    [2]ZIFF OJ,KOTECHA D.Digoxin:The good and the bad[J].Trends Cardiovasc Med,2016,26(7):585-595.
    [3]周玥,张学景,蔡于琛,等.蛋白磷酸酶1和2A抑制剂的研究进展[J].中国药学杂志,2007,42(5):324-328.
    [4]CHIANG DY,HECK AJ,DOBREV D,et al.Regulating the regulator:Insights into the cardiac protein phosphatase 1interactome[J].J Mol Cell Cardiol,2016,101:165-172.
    [5]薛书银,李莎,张梦丹,等.去乙酰毛花苷和米力农对大鼠血流动力学作用的比较[J].中国药理学与毒理学杂志,2017,31(2):179-186.
    [6]SCHULTE JS,FEHRMANN E,TEKOOK MA,et al.Cardiac expression of the CREM repressor isoform CREM-Ib△C-X in mice leads to arrhythmogenic alterations in ventricular cardiomyocytes[J].Basic Res Cardiol,2016,111(2):15.
    [7]MACZEWSKI M,MACKIEWICZ U.Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+handling in the post-infarction rat heart[J].Cardiovasc Res,2008,79(1):42-51.